Literature DB >> 8439645

Species-specific properties of the glomerular mesangium.

J D Sraer1, C Adida, M N Peraldi, E Rondeau, A Kanfer.   

Abstract

Mesangial cells play a central role in the physiology and pathophysiology of the glomerulus. To date, most of the in vitro studies have been performed in cultured rat mesangial cells, with only 10% of them performed in human mesangial cells. In this article, the major differences between results obtained with these two types of cultured cells will be reviewed. In rats and in humans, most of the mesangial cells appear to be of smooth muscle origin. In the rat, some of the cultured cells also express a phenotype suggesting a monocyte/macrophage origin. Phagocytosis and synthesis of cytokines or proinflammatory proteins that have been described in cultured rat cells seem mostly linked to this monocyte/macrophage subtype of resident mesangial cells. In humans, macrophages are only detected in pathologic conditions, suggesting that they are not resident but rather infiltrating cells. Mesangial receptors, most notably angiotensin II receptors, are clearly present on mesangial cell membranes and are linked to prostaglandin E2 synthesis and to cell contraction. In humans, spontaneous prostanoid synthesis is low and is increased by the induction of cyclooxygenase by sodium butyrate in the medium. Even so, the amount of prostaglandin E2 synthesized by human mesangial cells is quantitatively low comparatively with that in rats. In rats, accordingly, mesangial cells play a role in the regulation of single-nephron GFR. In humans, angiotensin II also exerts a control on GFR but it is more difficult to demonstrate its contractile effect on human than on rat mesangial cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439645     DOI: 10.1681/ASN.V371342

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  9 in total

1.  siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA.

Authors:  Jonathan E Zuckerman; Aaron Gale; Peiwen Wu; Rong Ma; Mark E Davis
Journal:  Nucleic Acid Ther       Date:  2015-03-03       Impact factor: 5.486

2.  Morphine stimulates mesangial cell TNF-alpha and nitrite production.

Authors:  A A Kapasi; N Gibbons; J Mattana; P C Singhal
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

3.  Receptor mediated endocytosis by mesangial cells modulates transmigration of macrophages.

Authors:  P C Singhal; S Gupta; P Sharma; H Shah; N Shah; P Patel
Journal:  Inflammation       Date:  2000-12       Impact factor: 4.092

Review 4.  Mesangial pathology in glomerular disease: targets for therapeutic intervention.

Authors:  Yogesh M Scindia; Umesh S Deshmukh; Harini Bagavant
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

5.  Morphine modulates cathepsin B and L activity in isolated glomeruli and mesangial cells.

Authors:  P C Singhal; S Sagar; N Gibbons
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

6.  Morphine stimulates superoxide formation by glomerular mesangial cells.

Authors:  P C Singhal; M Pamarthi; R Shah; D Chandra; N Gibbons
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

7.  A2 adenosine receptors in human glomerular mesangial cells.

Authors:  V Stefanović; P Vlahović
Journal:  Experientia       Date:  1995-04-15

8.  Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity.

Authors:  P C Singhal; S Sagar; D Chandra; P Garg
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

9.  Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis.

Authors:  Ling Guo; Shi Luo; Zhengwu Du; Meiling Zhou; Peiwen Li; Yao Fu; Xun Sun; Yuan Huang; Zhirong Zhang
Journal:  Nat Commun       Date:  2017-10-12       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.